The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia

The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia

Arrhythmia is a quivering or irregular heartbeat that can often lead to blood clots, stroke, heart failure, and other heart-related complications. The limited efficacy and safety of antiarrhythmic drugs require the design of new compounds. Previous research indicated that pyrrolidin-2-one derivative...

Full description

Bibliographic Details
Main Authors:	Klaudia Lustyk, Kinga Sałaciak, Paula Zaręba, Agata Siwek, Jacek Sapa, Karolina Pytka
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Pharmaceuticals
Subjects:	arrhythmia antiarrhythmic effect adrenaline-induced arrhythmia α<sub>1</sub>-adrenoceptor α<sub>1</sub>-adrenolytics pyrrolidin-2-one
Online Access:	https://www.mdpi.com/1424-8247/14/11/1065

Similar Items

The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α<sub>1</sub>-Adrenolytic Properties
by: Klaudia Lustyk, et al.
Published: (2022-09-01)

HBK-10, A Compound with α<sub>1</sub>-Adrenolytic Properties, Showed Antiarrhythmic and Hypotensive Effects in Rats
by: Klaudia Lustyk, et al.
Published: (2022-10-01)

Chemically homogenous compounds with antagonistic properties at all α1-adrenoceptor subtypes but not β1-adrenoceptor attenuate adrenaline-induced arrhythmia in rats
by: Karolina Pytka, et al.
Published: (2016-08-01)

The Subtype Selectivity in Search of Potent Hypotensive Agents among 5,5-Dimethylhydantoin Derived α<sub>1</sub>-Adrenoceptors Antagonists
by: Aneta Kaczor, et al.
Published: (2023-11-01)

Cardiac and Vascular α<sub>1</sub>-Adrenoceptors in Congestive Heart Failure: A Systematic Review
by: Gizem Kaykı-Mutlu, et al.
Published: (2020-11-01)

Class I and Class III Antiarrhythmic Agents: Mechanisms of Action and the Problem of Proarrhythmic Activity
by: Vidal Essebag
Published: (2020-12-01)

Effects of Nebulized Adrenaline on Cardiac Rhythm in Children
by: Halise Akça, et al.
Published: (2019-12-01)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
by: Joanne J. A. van Bavel, et al.
Published: (2018-02-01)

Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
by: Gavras Haralambos, et al.
Published: (2001-11-01)

Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT<sub>1A</sub> and D<sub>2</sub> Receptors
by: Kinga Sałaciak, et al.
Published: (2021-07-01)

Persistence to Medications for Benign Prostatic Hyperplasia/Benign Prostatic Obstruction-Associated Lower Urinary Tract Symptoms in the ASL TO4 Regione Piemonte (Italy)
by: Lucrezia Greta Armando, et al.
Published: (2022-12-01)

Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties
by: Vittorio Canale, et al.
Published: (2021-06-01)

In search of optimal treatment for nonischemic ventricular arrhythmia in patients with anxiety disorders
by: T V Treshkur, et al.
Published: (2012-12-01)

THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS
by: Yu. A. Bunin
Published: (2016-01-01)

Differential Effects of Angiotensin-II Compared to Phenylephrine on Arterial Stiffness and Hemodynamics: A Placebo-Controlled Study in Healthy Humans
by: Klaas F. Franzen, et al.
Published: (2021-05-01)

EEG Frequency Correlates with α<sub>2</sub>-Receptor Density in Parkinson’s Disease
by: Adam F. Kemp, et al.
Published: (2024-02-01)

Characterization of Chicken α<sub>2A</sub>-Adrenoceptor: Molecular Cloning, Functional Analysis, and Its Involvement in Ovarian Follicular Development
by: Biying Jiang, et al.
Published: (2022-06-01)

Effect of Different Doses of Atipamezole on Reversal of Medetomidine-Induced Tear-Flow Decrease in Rats
by: Teppei Kanda, et al.
Published: (2020-12-01)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
by: Sean P. Gaine, et al.
Published: (2023-04-01)

Antiarrhythmic Drug Dosing in Children—Review of the Literature
by: Nathalie Oeffl, et al.
Published: (2023-05-01)

The prevalence of arrhythmias in congenital heart patients and the response rate to antiarrhythmic treatment; A single center study
by: Mina Jamlou, et al.
Published: (2018-01-01)

Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system
by: Feifei Wang, et al.
Published: (2023-05-01)

The Role of Adrenoceptors in the Retina
by: Yue Ruan, et al.
Published: (2020-12-01)

A new electrocardiographic parameter associated with sudden cardiac death in pulmonary sarcoidosis
by: Samim Emet, et al.
Published: (2019-10-01)

On the sum of powers of the $ A_{\alpha} $-eigenvalues of graphs
by: Zhen Lin
Published: (2022-06-01)

What an emergency physician needs to know about acute care of cardiac arrhythmias
by: Stellbrink Christoph
Published: (2010-01-01)

ADVANTAGES OF USING OF ANTIARRHYTHMIC HERBAL REMEDIES IN TREATMENT DIFFERENT TYPES OF CARDIAC ARRHYTHMIAS
by: Kapustnick Yu. A.
Published: (2018-12-01)

Comparative Effectiveness of Acupuncture and Antiarrhythmic Drugs for the Prevention of Cardiac Arrhythmias: A Systematic Review and Meta-analysis of Randomized Controlled Trials
by: Yanda Li, et al.
Published: (2017-06-01)

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
by: V. L. Doshchitsin, et al.
Published: (2022-07-01)

Participation of hepatic α/β-adrenoceptors and AT1 receptors in glucose release and portal hypertensive response induced by adrenaline or angiotensin II
by: L.J.T. de Araújo, et al.
Published: (2018-11-01)

Editorial: Perspectives of Antiarrhythmic Drug Therapy: Disappointing Past, Current Efforts, and Faint Hopes
by: Péter P. Nánási, et al.
Published: (2020-07-01)

Effect of Intramuscular Medetomidine Administration on Tear Flow in Rats
by: Teppei Kanda, et al.
Published: (2020-04-01)

Prediction of antiarrhythmic therapy effectiveness in children
by: L. I. Svintsova, et al.
Published: (2019-08-01)

Botulinum Toxin-Chitosan Nanoparticles Prevent Arrhythmia in Experimental Rat Models
by: David Sergeevichev, et al.
Published: (2020-08-01)

Inhibiting Intracellular α<sub>2C</sub>-Adrenoceptor Surface Translocation Using Decoy Peptides: Identification of an Essential Role of the C-Terminus in Receptor Trafficking
by: Aisha Raza, et al.
Published: (2023-12-01)

Activity of kallikrein-kinin system at patients with asiderotic anemia
by: N. N. Zhilkova
Published: (2004-06-01)

Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy
by: Chandra Prajapati, et al.
Published: (2018-02-01)

The α 1-adrenolytic and structural evaluation of new pyridoindole derivatives
by: Májeková Magdaléna, et al.
Published: (2006-12-01)

When the Gates Swing Open Only: Arrhythmia Mutations That Target the Fast Inactivation Gate of Na<sub>v</sub>1.5
by: Tamer M. Gamal El-Din
Published: (2022-11-01)

Novel Arylpiperazine Derivatives of Salicylamide with α<sub>1</sub>-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats
by: Elżbieta Żmudzka, et al.
Published: (2022-12-01)